Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial

Francisco M. Marty, Amanda Peppercorn, Petr Husa et al.|The Lancet Respiratory Medicine|2017

Cited by 104